Pritpal Malhi
Role not yet determined Is this you? Add your title
Also affiliated: Guru Nanak Dev University (1985–1988)
Formerly Arkansas Affiliated with NCTR through 2024.
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Pritpal Malhi's research focuses on evaluating the genotoxic effects of various substances, particularly organophosphorus pesticides. His work has involved in vivo studies using bone marrow cells in rats to assess chromosomal aberrations and micronuclei induction. Malhi has also investigated genotoxicity in plant systems, specifically root meristems of Allium and Hordeum. More recently, his research has extended to evaluating genotoxicity using primary hepatocytes isolated from rhesus macaques and integrating the rat liver micronucleus assay into longer treatment protocols for assessing carcinogens. He has also contributed to reviews on specific compounds like bexarotene and explored the application of mass spectrometry imaging for identifying toxicity markers in developmental studies.
Metrics
- h-index: 5
- Publications: 8
- Citations: 99
Positions
-
Veterinary Pathologist 2016–2019CiToxLAB North America - A Charles River Company ORCID
-
Veterinary Pathologist 2013–2015Prairie Diagnostic Services Inc at the University of Saskatchewan ORCID
Selected Publications
-
Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities (2025)
-
The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses (2024)
Collaboration Network
Top Collaborators
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities
- Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities
- Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities
- Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities
- Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities
Similar Researchers
Based on overlapping research topics